NASDAQ:PRPO Precipio Inc Target PTs 11 --> 6.20 --> 14.80 and higher Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic...
NASDAQ:CING Cingulate Inc Target PT 33 and higher Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine)...
NYSE:FATH Fathom Digital Manufacturing Corporation Target PT 18 and higher Fathom Digital Manufacturing Corporation, a digital manufacturing platform, provides product development and manufacturing services in North America. It provides plastic and metal additive manufacturing, computer numerical control machining, injection molding and tooling, precision sheet...
NASDAQ:FAMI Farmmi Inc entry PT 1.10-ish Target PTs 4 --> 8.60 and higher Farmmi, Inc., together with its subsidiaries, processes and sells agricultural products in China, the United States, Japan, Canada, Europe, Korea, and the Middle East. The company offers shiitake and Mu Er mushrooms; and other edible fungi products, including bamboo fungi, agrocybe...
NASDAQ:HUBC Hub Cyber Security Ltd entry 2.08-ish Target PTs 4.30 --> 9 and higher HUB Cyber Security Ltd. provides cyber security solutions in Israel and internationally. The company offers HUB Secure File Vault, a super charged managed file transfer backed by dedicated hardware driven security, which creates a secure enclave to protect the organization's data...
NASDAQ:PIXY ShiftPixy Inc entry PTs 4.79 - 5-ish Target PTs 15 --> 29 --> 49 and higher ShiftPixy, Inc., together with its subsidiaries, provides staffing solutions in the United States. It offers employment administrative services, such as payroll processing, human resources consulting, and workers' compensation administration and coverage. The company operates...
NASDAQ:ADXN Addex Therapeutics Ltd ADR entry PT 5 Target PTs 9 --> 12 --> 20 and higher Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of G-protein coupled...
NASDAQ:SAVA Cassava Sciences Inc Long term PT 145 and higher Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a...
NASDAQ:PLUG Plug Power Inc Long term PTs 75 - 105 and higher Plug Power Inc. delivers end-to-end clean hydrogen and zero-emissions fuel cell solutions for supply chain and logistics applications, on-road electric vehicles, stationary power market, and others in North America and internationally. It engages in building an end-to-end green hydrogen ecosystem,...
NASDAQ:OCGN Ocugen Inc Long term PTs 16 - 21 - 180 and higher Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited...
NASDAQ:NVAX Novavax, Inc. Long term PT 360 and higher Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to...
NASDAQ:FCEL Fuelcell Energy Inc Long term PTs 39 - 682 and higher FuelCell Energy, Inc., together with its subsidiaries, manufactures and sells stationary fuel cell and electrolysis platforms that decarbonize power and produce hydrogen. The company provides various configurations and applications of its platform, including on-site power, utility grid support,...
NASDAQ:MVIS Microvision Inc. Long term PTs 46 - 87 -548 and higher MicroVision, Inc. develops and sells lidar sensors used in automotive safety and autonomous driving applications. Its laser beam scanning technology is based on micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company also...
NASDAQ:ESPR Esperion Therapeutics Inc. Long term PTs 39 - 53 - 76 and higher Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for...
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and chimeric adaptors to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance...
NASDAQ:AGRX Agile Therapeutics Inc Long term PTs 6 - 14.50 - 38 and higher Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The...
NASDAQ:NRXP NRX Pharmaceuticals Inc Long term PTs 1.20 - 1.50 - 3.50 - 10 and higher NRx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related...
Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the blockchain ecosystem and the generation of digital assets in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings,...